| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |